IL-18BP ANTAGONIST ANTIBODIES AND THEIR USE IN MONOTHERAPY AND COMBINATION THERAPY IN THE TREATMENT OF CANCER

The present invention is directed to anti-IL18-BP antibodies and uses thereof. The present invention is directed to monotherapy and combination treatments with for example immune checkpoint inhibitor antibodies, as described herein. La presente invención se dirige a anticuerpos anti-IL18-BP y usos d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TILLEMAN Hadas Galon, FRIDMAN-KFIR Tal, COJOCARU Gad, SEVER Iital, GALPERIN Moran, OPHIR Eran, ALTEBER Zoya, LEIDERMAN Olga, BLAT Dan, MENA Assaf, TOPORIK Amir, NIELSON Nels P, ERLICH Ziv, CHIASSON Alissa M, COHEN Nadav, PERPINIAL Michal, TATIROVSKY Evgeny, NOVIK Amit
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention is directed to anti-IL18-BP antibodies and uses thereof. The present invention is directed to monotherapy and combination treatments with for example immune checkpoint inhibitor antibodies, as described herein. La presente invención se dirige a anticuerpos anti-IL18-BP y usos de estos. La presente invención se dirige a monoterapia y tratamientos de combinación con, por ejemplo, anticuerpos inhibidores de puntos de control inmunitarios, como se describe en la presente.